Last Updated On 8/22/2022 9:16:12 AM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
Employment |
No Relationships to Disclose |
|
|
Leadership |
Company: OncoPep |
Recipient: You |
Company: C4 Therapeutics |
Recipient: You |
Company: Mana Therapeutics |
Recipient: You |
Company: Raqia Therapeutics |
Recipient: You |
Company: NextRNA |
Recipient: You |
Company: starton therapeutics |
Recipient: You |
Company: window therapeutics |
Recipient: You |
|
Stock and Other Ownership Interests |
Company: C4 Therapeutics |
Recipient: You |
Company: OncoPep |
Recipient: You |
Company: Mana Therapeutics |
Recipient: You |
Company: Raqia Therapeutics |
Recipient: You |
Company: NextRNA |
Recipient: You |
Company: STARTON Therapeutics |
Recipient: You |
Company: Window Therapeutics |
Recipient: You |
|
Honoraria |
No Relationships to Disclose |
|
|
Consulting or Advisory Role |
Company: Millennium |
Recipient: You |
Company: Bristol-Myers Squibb |
Recipient: You |
Company: Janssen Oncology |
Recipient: You |
Company: Sanofi |
Recipient: You |
Company: Precision Biosciences |
Recipient: You |
Company: Pfizer |
Recipient: You |
Company: amgen |
Recipient: You |
Company: AstraZeneca |
Recipient: You |
Company: oncopeptides |
Recipient: You |
|
Speakers' Bureau |
No Relationships to Disclose |
|
|
Research Funding |
No Relationships to Disclose |
|
|
Patents, Royalties, Other Intellectual Property |
Please describe: C4 Therapeutics |
Recipient: You |
Please describe: Oncopep |
Recipient: You |
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
No Relationships to Disclose |
|
|
Other Relationship |
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships |
not answered |
|
|
(OPTIONAL) Open Payments Link |
not answered |
|
|